DGAP-News

SYNLAB to continue providing COVID-19 testing at UEFA competition matches and UEFA EURO 2020 - Seite 2

Underlining UEFA's commitment to reliable testing procedures and the rigorous Return to Play protocol, Giorgio Marchetti, UEFA deputy secretary, adds: "As the fight against the COVID-19 pandemic continues, the health and well-being of players, staff, referees and everyone operating in the stadium remains to be our absolute priority. The last year has shown that partnering with an industry leader like SYNLAB allows us to ensure that all UEFA competition matches are played in an as safe as possible environment. We are looking forward to continuing this successful cooperation with SYNLAB".

For more information:

Media contact: Florian Brueckner, FTI Consulting	[phone] [e-mail]
Investor contact: Mark Reinhard, SYNLAB	[phone] [e-mail]

 

About SYNLAB

• SYNLAB, (ISIN: DE000A2TSL71, SYMBOL: SYAB) is the largest European clinical laboratory and medical diagnostic services company and offers a full range of innovative and reliable medical diagnostics for patients, practising doctors, clinics and the pharmaceutical industry.
• Providing the leading level of service within the industry, SYNLAB is the partner of choice for diagnostics in human and veterinary medicine. The Group continuously innovates medical diagnostic services for the benefit of patients and customers.
• SYNLAB operates in 36 countries across four continents and holds leading positions in most markets. Around 20,000 employees, including over 1,200 medical experts, as well as a large number of other specialists such as biologists, chemists and laboratory technicians, contribute every day to the Group's worldwide success. SYNLAB carries out ~500 million laboratory tests per year and achieved revenues of EUR 2.6 billion in 2020.
• More information can be found on www.synlab.com